273 related articles for article (PubMed ID: 29132361)
1. The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.
Guo Z; Guan X; Shi L
BMC Health Serv Res; 2017 Nov; 17(1):723. PubMed ID: 29132361
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.
Xu S; Bian C; Wang H; Li N; Wu J; Li P; Lu H
BMC Health Serv Res; 2015 Sep; 15():403. PubMed ID: 26394615
[TBL] [Abstract][Full Text] [Related]
3. Organizational barriers associated with the implementation of national essential medicines policy: A cross-sectional study of township hospitals in China.
Yang L; Liu C; Ferrier JA; Zhang X
Soc Sci Med; 2015 Nov; 145():201-8. PubMed ID: 26360408
[TBL] [Abstract][Full Text] [Related]
4. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
[TBL] [Abstract][Full Text] [Related]
5. The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China.
Wang Y; Zhu Y; Shi H; Sun X; Chen N; Li X
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31698773
[No Abstract] [Full Text] [Related]
6. Distribution of essential medicines to primary care institutions in Hubei of China: effects of centralized procurement arrangements.
Yang L; Huang C; Liu C
BMC Health Serv Res; 2017 Nov; 17(1):727. PubMed ID: 29137645
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China.
Wang X; He X; Ren Y; Zhang Z; Cai L; Cao Z; Li X
Front Public Health; 2022; 10():860471. PubMed ID: 35493374
[TBL] [Abstract][Full Text] [Related]
8. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
Guan X; Hu H; Man C; Shi L
Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
[TBL] [Abstract][Full Text] [Related]
9. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program.
Chen M; Wang L; Chen W; Zhang L; Jiang H; Mao W
Pharmacoeconomics; 2014 Mar; 32(3):245-55. PubMed ID: 23813440
[TBL] [Abstract][Full Text] [Related]
10. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.
Zhang X; Wu Q; Liu G; Li Y; Gao L; Guo B; Fu W; Hao Y; Cui Y; Huang W; Coyte PC
BMJ Open; 2014 Dec; 4(12):e006471. PubMed ID: 25534214
[TBL] [Abstract][Full Text] [Related]
11. How China's new health reform influences village doctors' income structure: evidence from a qualitative study in six counties in China.
Zhang S; Zhang W; Zhou H; Xu H; Qu Z; Guo M; Wang F; Zhong Y; Gu L; Liang X; Sa Z; Wang X; Tian D
Hum Resour Health; 2015 May; 13():26. PubMed ID: 25940189
[TBL] [Abstract][Full Text] [Related]
12. Prices, availability, and affordability of national essential medicines in public primary hospitals: A cross-sectional survey in poverty-stricken rural areas in China.
Xu R; Li S; Lv X; Xie X
Int J Health Plann Manage; 2020 Mar; 35(2):545-557. PubMed ID: 31736154
[TBL] [Abstract][Full Text] [Related]
13. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
14. Availability of essential medicines in selected public, primary and secondary health care institutions of a rural Sri Lankan district: a spot survey.
Rathish D; Premarathna I; Jayathilake T; Kandegedara C; Punchihewa K; Ananda L; Bandara T; Jayasumana C; Siribaddana S
BMC Health Serv Res; 2017 Jan; 17(1):11. PubMed ID: 28056960
[TBL] [Abstract][Full Text] [Related]
15. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
16. The effect of essential medicines programme on rational use of medicines in China.
Gong Y; Yang C; Yin X; Zhu M; Yang H; Wang Y; Li Y; Liu L; Dong X; Cao S; Lu Z
Health Policy Plan; 2016 Feb; 31(1):21-7. PubMed ID: 25823750
[TBL] [Abstract][Full Text] [Related]
17. Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji.
Huang Y; Jiang Y; Zhang L; Mao W; van Boven JFM; Postma MJ; Chen W
BMC Health Serv Res; 2018 Mar; 18(1):218. PubMed ID: 29587742
[TBL] [Abstract][Full Text] [Related]
18. Estimating benefit equity of government health subsidy in healthcare Services in Shandong Province, China: a cross-sectional study.
Qin W; Xu L; Li J; Sun L; Ding G; Shao H; Xu N
Int J Equity Health; 2018 May; 17(1):61. PubMed ID: 29776366
[TBL] [Abstract][Full Text] [Related]
19. Perceived impacts of the national essential medicines system: a cross-sectional survey of health workers in urban community health services in China.
Zhang T; Liu C; Ren J; Wang S; Huang X; Guo Q
BMJ Open; 2017 Jul; 7(7):e014621. PubMed ID: 28698322
[TBL] [Abstract][Full Text] [Related]
20. The availability, price and affordability of antidiabetic drugs in Hubei province, China.
Gong S; Cai H; Ding Y; Li W; Juan X; Peng J; Jin S
Health Policy Plan; 2018 Oct; 33(8):937-947. PubMed ID: 30215707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
